General Information of Drug Transporter (DT)
DT ID	DTD0319 Transporter Info
Gene Name	SLC36A2
Transporter Name	Proton-coupled amino acid transporter 2
Gene ID	153201
UniProt ID	Q495M3

Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)
Approved Drug
Cisplatin	1 DT Activity Modulations Related to This Exogenous Factor			Click to Show/Hide the Full List
DT Modulation 1	Cisplatin increases the expression of SLC36A2				[1]
Discontinued Drug
NOX-200	1 DT Activity Modulations Related to This Exogenous Factor			Click to Show/Hide the Full List
DT Modulation 1	NOX-200 inhibits the activity of SLC36A2				[2]
Investigative Drug
5-Hydroxy-L-tryptophan	1 DT Activity Modulations Related to This Exogenous Factor			Click to Show/Hide the Full List
DT Modulation 1	5-Hydroxy-L-tryptophan inhibits the activity of SLC36A2				[2]

References
1	Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
2	Amino acid derivatives are substrates or non-transported inhibitors of the amino acid transporter PAT2 (slc36a2). Biochim Biophys Acta. 2011 Jan;1808(1):260-70.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.